Estimations des analystes de Wall Street pour Codexis, Inc. (CDXS): objectif de cours de consensus, recommandations achat/conserver/vente et prévisions de revenus, BPA et EBITDA pour les prochains exercices.
Consensus des analystes
| Achat fort | 0 |
| Achat | 9 |
| Conserver | 5 |
| Vente | 0 |
| Vente forte | 0 |
| Analystes au total | 14 |
| Note moyenne (1-5) | 0.64 |
Surprises de Résultats Récentes
| Date | BPA Réel | BPA Estimé | vs Est. |
|---|---|---|---|
| 2026-11-05 | $-0.09 | ||
| 2026-08-11 | $-0.13 | $-0.14 | +8.2% |
| 2026-05-07 | $-0.10 | $-0.11 | +9.1% |
| 2026-03-11 | $0.11 | $0.01 | +1000.0% |
| 2025-11-06 | $-0.22 | $-0.15 | -46.7% |
| 2025-08-13 | $-0.16 | $-0.17 | +5.9% |
| 2025-05-14 | $-0.25 | $-0.20 | -25.0% |
| 2025-02-27 | $-0.13 | $-0.04 | -225.0% |
Ratios de valorisation
| Prix / Valeur comptable | 3.70 |
| EV / EBITDA | -9.37 |
| Rendement du dividende | 0.00% |
Compte de Résultat (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenus | $48.8M | $50.0M | $60.6M | $68.5M | $69.1M | $104.8M | $138.6M | $70.1M | $59.3M | $70.4M |
| Coût des Ventes | $9.8M | $14.3M | $12.6M | $15.6M | $13.7M | $22.2M | $38.0M | $12.8M | $16.3M | $9.3M |
| Marge Brute | $39.1M | $35.7M | $48.0M | $52.8M | $55.3M | $82.5M | $100.6M | $57.3M | $43.1M | $61.0M |
| R&D | $22.2M | $29.7M | $30.0M | $33.9M | $44.2M | $55.9M | $80.1M | $58.9M | $46.3M | $52.3M |
| Frais Généraux | $25.4M | $29.0M | $29.3M | $31.5M | $35.0M | $49.3M | $52.2M | $53.2M | $55.1M | $47.1M |
| Charges Opérationnelles | $47.6M | $58.7M | $59.3M | $65.4M | $79.2M | $105.2M | $135.4M | $125.4M | $101.6M | $99.4M |
| Résultat Opérationnel | -$8.6M | -$23.0M | -$11.3M | -$12.5M | -$23.9M | -$22.7M | -$34.9M | -$68.1M | -$58.5M | -$38.3M |
| EBITDA | -$4.0M | -$21.9M | -$10.1M | -$8.0M | -$19.4M | -$15.1M | -$26.3M | -$49.3M | -$53.4M | -$33.9M |
| Charges d'Intérêt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $4.8M |
| Résultat Avant Impôts | -$8.6M | -$22.9M | -$10.9M | -$11.9M | -$23.7M | -$21.1M | -$33.3M | -$76.2M | -$65.2M | -$43.9M |
| Impôts | -$40000 | $81000 | -$37000 | $17000 | $339000 | $189000 | $276000 | $69000 | $34000 | $47000 |
| Résultat Net | -$8.6M | -$23.0M | -$10.9M | -$11.9M | -$24.0M | -$21.3M | -$33.6M | -$76.2M | -$65.3M | -$44.0M |
| BPA | $-0.21 | $-0.50 | $-0.21 | $-0.21 | $-0.40 | $-0.33 | $-0.51 | $-1.12 | $-0.89 | $-0.50 |
| BPA Dilué | $-0.21 | $-0.50 | $-0.21 | $-0.21 | $-0.40 | $-0.33 | $-0.51 | $-1.12 | $-0.89 | $-0.50 |
| Actions en Circulation (Diluées) | $40.6M | $46.2M | $52.2M | $56.5M | $59.4M | $64.6M | $65.3M | $68.1M | $73.4M | $87.1M |
Prix
| Prix | $1.34 |
| Capitalisation | $144M |
| Bourse | NASDAQ |
| Pays | US |
Entreprises liées: ARMP · CCCC · GNFT · IMDX · IPHA · IVVD · OABI
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de CDXS: Vue d'ensemble · Financiers · Valorisation · Statistiques · Technique · Actionnariat · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions